Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Quality Inconsistency and Supplier Reliability Suppliers who don't meet standards pose big problems beyond not following the rules
Impact of Coverage of GLP-1 Drugs for Obesity on Medicare Expenditure s Source: JAMA Health Forum Hwang, April 25, 2025 Researchers in JAMA Health Forum used a microsimulation model to assess the likely financial results of Medicare covering GLP-1 drugs for obesity
However, they may offer a more flexible and accessible option for patients when commercially available treatments are not suitable or available
US$ 25.04
US$ 27.63
US$ 22.83
US$ 25.78
US$ 27.81
US$ 29.65
